Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/96184
Title: | In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis | Authors: | Wong, ILK Chan, KF Chen, YF Lun, ZR Chan, TH Chow, LMC |
Issue Date: | Jun-2014 | Source: | Antimicrobial agents and chemotherapy, June 2014, v. 58, no. 6, p. 3379-3388 | Abstract: | Treatment of leishmaniasis by chemotherapy remains a challenge because of limited efficacy, toxic side effects, and drug resistance. We previously reported that synthetic flavonoid dimers have potent antipromastigote and antiamastigote activity against Leishmania donovani, the causative agent of visceral leishmaniasis. Here, we further investigate their leishmanicidal activities against cutaneous Leishmania species. One of the flavonoid dimers (compound 39) has marked antipromastigote (50% inhibitory concentrations [IC50s], 0.19 to 0.69 μM) and antiamastigote (IC50s, 0.17 to 2.2 μM) activities toward different species of Leishmania that cause cutaneous leishmaniasis, including Leishmania amazonensis, Leishmania braziliensis, Leishmania tropica, and Leishmania major. Compound 39 is not toxic to peritoneal elicited macrophages, with IC50 values higher than 88 μM. In the mouse model of cutaneous leishmaniasis induced by subcutaneous inoculation of L. amazonensis in mouse footpads, intralesional administration of 2.5 mg/kg of body weight of compound 39.HCl can reduce footpad thickness by 36%, compared with that of controls values. The amastigote load in the lesions was reduced 20-fold. The present study suggests that flavonoid dimer 39 represents a new class of safe and effective leishmanicidal agent against visceral and cutaneous leishmaniasis. | Publisher: | American Society for Microbiology | Journal: | Antimicrobial agents and chemotherapy | ISSN: | 0066-4804 | EISSN: | 1098-6596 | DOI: | 10.1128/AAC.02425-13 | Rights: | Copyright © 2014, American Society for Microbiology. All Rights Reserved. This manuscript version is made available under a CC-BY Creative Commons license (https://creativecommons.org/about/cclicenses/). The following publication is published in Antimicrobial Agents and Chemotherapy, available at https://doi.org/10.1128/AAC.02425-13. |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
In vitro_and in vivo_efficacy.pdf | Pre-Published version | 947.77 kB | Adobe PDF | View/Open |
Page views
58
Last Week
0
0
Last month
Citations as of Sep 22, 2024
Downloads
35
Citations as of Sep 22, 2024
SCOPUSTM
Citations
30
Citations as of Sep 26, 2024
WEB OF SCIENCETM
Citations
25
Citations as of Sep 26, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.